RecruitingNCT00034216

Collection of Blood From Patients With Cancer

Biospecimen Acquisition From Human Subjects

Sponsor

National Cancer Institute (NCI)

Enrollment

1,750 participants

Start Date

Jul 16, 2002

Study Type

OBSERVATIONAL

Conditions

Breast Cancer Liver Cancer Prostate Cancer Lung Cancer Colon Cancer

Summary

This study will collect blood from patients with cancer to study the level of cells which decrease the immune response (suppressor cells) before and after chemotherapy. Patients 18 years of age and older with cancer may participate. This study does not involve treatment. Participants will have about 50 ml (3 tablespoonfuls) of blood drawn. Depending on their condition, patients may be invited to enroll in a clinical research study involving chemotherapy, radiotherapy, or surgery. Additional 40-ml blood samples may be drawn during the course of treatment.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects blood samples from people with cancer or suspected cancer — as well as healthy volunteers — to support ongoing research into how cancer develops and how it might be better treated. **You may be eligible if...** - You are 18 years of age or older - You have a known or suspected cancer diagnosis - You are a healthy volunteer **You may NOT be eligible if...** - There are no exclusion criteria Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.